Table 2.
Cancer-specific survival |
Overall survival | |
---|---|---|
Histology | ||
Serous | Referent | Referent |
Carcinosarcoma | 1.79 (1.68-1.91)* | 1.76 (1.65-1.87)* |
Age (years) | ||
<50 | Referent | Referent |
50-64 | 1.36 (1.29-1.43)* | 1.41 (1.34-1.49)* |
65-74 | 1.73 (1.63-1.82)* | 1.88 (1.78-1.98)* |
≥75 | 2.39 (2.25-2.53)* | 2.77 (2.62-2.93)* |
Race | ||
White | Referent | Referent |
Black | 1.11 (1.03-1.20)* | 1.16 (1.08-1.25)* |
Other/unknown | 0.96 (0.88-1.03) | 0.99 (0.92-1.06) |
Year of diagnosis | ||
1988-1990 | Referent | Referent |
1991-1993 | 0.97 (0.90-1.04) | 0.94 (0.88-1.01) |
1994-1995 | 0.90 (0.83-0.98)* | 0.87 (0.81-0.94)* |
1996-1997 | 0.89 (0.82-0.96)* | 0.85 (0.79-0.92)* |
1998-1999 | 0.90 (0.83-0.97)* | 0.85 (0.79-0.92)* |
2000-2001 | 0.89 (0.83-0.96)* | 0.85 (0.80-0.91)* |
2002-2003 | 0.82 (0.77-0.89)* | 0.79 (0.74-0.85)* |
2004-2005 | 0.81 (0.75-0.87)* | 0.78 (0.73-0.84)* |
2006-2007 | 0.76 (0.68-0.84)* | 0.73 (0.66-0.80)* |
Marital status | ||
Married | Referent | Referent |
Unmarried | 1.13 (1.09-1.17)* | 1.16 (1.12-1.20)* |
Unknown | 0.99 (0.88-1.11) | 1.02 (0.91-1.13) |
SEER registry | ||
Eastern | Referent | Referent |
Midwest | 1.15 (1.10-1.21)* | 1.14 (1.08-1.19)* |
West | 1.04 (1.00-1.09) | 1.04 (0.99-1.08) |
Stage1 | ||
I | Referent | Referent |
II | 2.59 (2.30-2.92)* | 1.91 (1.74-2.11)* |
IIIA | 4.02 (3.45-4.68)* | 2.65 (2.32-3.03)* |
IIIB | 5.20 (4.57-5.91)* | 3.40 (3.04-3.79)* |
IIIC | 6.56 (5.95-7.23)* | 4.26 (3.95-4.59)* |
IIINOS | 7.06 (6.36-7.84)* | 4.59 (4.22-4.99)* |
IV | 9.18 (8.33- 10.12)* |
5.88 (5.45-6.34)* |
Unknown | 6.25 (5.41-7.22)* | 4.19 (3.70-4.75)* |
P<0.05